Martin Dekker Insider Trading

FREE EMAIL WATCHDOG

Get free email notifications about insider trading for Martin Dekker.

  • Your email is safe with us.
  • The service is free and you can unsubscribe at any time.

General | Insider Transactions | Monthly Overview

Get the latest insider transactions of Martin Dekker. Martin Dekker is a VP of Device Engineering in Bellerophon Therapeutics, Inc. ($BLPH) and a VP of Engineering & Manuf in Bellerophon Therapeutics, Inc. ($BLPH).

Address: C/O BELLEROPHON THERAPEUTICS, INC. 53 FRONTAGE ROAD, SUITE 301 HAMPTON 08827 NJ

Companies in which Martin Dekker is an Insider

Bellerophon Therapeutics, Inc.

Trading Symbol: BLPH
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Martin Dekker: VP of Engineering & Manuf, VP of Device Engineering
Holdings: 124,619 shares
Current Value: $82,249
Latest Transaction: Nov 19 2019
$BLPH Market Capitalization: $9.84M
$BLPH Previous Close: $0.66

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions

Latest Insider Trading Transactions of Martin Dekker

DateTickerCompanyOwnerRelationship Transaction Code Cost ($) Shares Transaction Value ($) Total Shares % Holdings
Nov 19 2019BLPHBellerophon Therap ...Dekker MartinVP of Engineering & ...Payment of ExerciseF0.3427,1349,226124,619151.8 K to 124.6 K (-17.88 %)
Sep 30 2019BLPHBellerophon Therap ...Dekker MartinVP of Engineering & ...Option ExerciseA0.50175,50087,750438,483
Sep 30 2019BLPHBellerophon Therap ...Dekker MartinVP of Engineering & ...Option ExerciseA0.50175,50087,750438,483
Jan 04 2019BLPHBellerophon Therap ...Dekker MartinVP of Engineering & ...Option ExerciseA0.8812,50011,000262,983
Nov 23 2018BLPHBellerophon Therap ...Dekker MartinVP of Engineering & ...Option ExerciseA0.91137,500125,125250,483
Sep 27 2018BLPHBellerophon Therap ...Dekker MartinVP of Engineering & ...GrantA0.0082,2430151,75369.5 K to 151.8 K (+118.32 %)
Jun 14 2018BLPHBellerophon Therap ...Dekker MartinVP of Engineering & ...Payment of ExerciseF2.377,47317,71169,51077 K to 69.5 K (-9.71 %)

View all Martin Dekker insider transactions.